Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Myriam Curet sold 5,318 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the sale, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Myriam Curet also recently made the following trade(s):
- On Friday, March 1st, Myriam Curet sold 1,605 shares of Intuitive Surgical stock. The shares were sold at an average price of $383.48, for a total transaction of $615,485.40.
- On Monday, February 12th, Myriam Curet sold 481 shares of Intuitive Surgical stock. The stock was sold at an average price of $386.09, for a total transaction of $185,709.29.
- On Friday, January 26th, Myriam Curet sold 4,318 shares of Intuitive Surgical stock. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70.
Intuitive Surgical Trading Down 0.5 %
Shares of ISRG stock opened at $373.12 on Friday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The firm’s 50 day moving average is $386.26 and its 200-day moving average is $345.39. The firm has a market capitalization of $132.35 billion, a price-to-earnings ratio of 67.35, a PEG ratio of 4.83 and a beta of 1.36.
Analyst Upgrades and Downgrades
Several brokerages recently commented on ISRG. Truist Financial lifted their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a report on Wednesday, January 24th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Raymond James lifted their target price on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a report on Friday, April 19th. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $396.17.
Check Out Our Latest Analysis on ISRG
Hedge Funds Weigh In On Intuitive Surgical
A number of large investors have recently modified their holdings of the stock. Flagship Harbor Advisors LLC grew its holdings in Intuitive Surgical by 4.2% during the 3rd quarter. Flagship Harbor Advisors LLC now owns 2,783 shares of the medical equipment provider’s stock worth $813,000 after acquiring an additional 113 shares during the period. DAVENPORT & Co LLC increased its holdings in Intuitive Surgical by 57.1% in the third quarter. DAVENPORT & Co LLC now owns 4,963 shares of the medical equipment provider’s stock valued at $1,451,000 after purchasing an additional 1,804 shares during the last quarter. Eastern Bank acquired a new position in Intuitive Surgical in the third quarter valued at about $656,000. Founders Financial Securities LLC boosted its holdings in Intuitive Surgical by 9.7% during the third quarter. Founders Financial Securities LLC now owns 1,629 shares of the medical equipment provider’s stock worth $476,000 after buying an additional 144 shares during the last quarter. Finally, Boston Trust Walden Corp grew its position in shares of Intuitive Surgical by 1.0% during the 3rd quarter. Boston Trust Walden Corp now owns 18,525 shares of the medical equipment provider’s stock worth $5,415,000 after buying an additional 185 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Best Aerospace Stocks Investing
- Hasbro’s Management Made All the Right Calls This Quarter
- What is the FTSE 100 index?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.